Mahul Amin, Vice President and Medical Director, Hospital Systems Operating Division at Labcorp, shared a post on LinkedIn:
“Last week I had the honor of presenting on “The clinical and pathological basis of renal cell carcinoma (RCC)” at the 3-day Workshop on Preclinical Models of RCC. It was an even greater privilege that my talk immediately followed a keynote by 2019 Nobel Laureate in Medicine, Dr. William Kaelin (Dana-Farber).
A big thank you to organizers James Brugarolas (UT Southwestern, Dallas) and Salvatore La Rosa, Chief Scientific Officer of Kidney Cancer Association (KCA). The meeting was hosted at the beautiful T. Boone Pickens Conference Center at UTSW.
The workshop brought together oncologists, urologists, pathologists, and basic scientists from around the world: an extraordinary fusion of science and medicine, with discovery, translation and care in active conversation. We were privileged to hear from keynote speakers of the highest caliber, including not one but two Nobel Laureates (The Nobel Prize ) in Medicine: Dr. William Kaelin (Dana-Farber) and Dr. Bruce Beutler (UTSW).
For patients and families whose courageous battles inspired this gathering, the connections forged here matter deeply. Preclinical models not only allow discoveries to be tested before reaching the clinic but also bring questions from the clinic back into the laboratory, accelerating progress toward new treatments and better outcomes.
I left the meeting motivated by the science, by the collaboration, and above all by the passion of the attendees to solve difficult and fundamental problems in our fight against RCC.”
More Posts Featuring Renal Cell Carcinoma.